Michele Olivieri

2.5k total citations · 1 hit paper
11 papers, 784 citations indexed

About

Michele Olivieri is a scholar working on Molecular Biology, Virology and Rheumatology. According to data from OpenAlex, Michele Olivieri has authored 11 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Virology and 2 papers in Rheumatology. Recurrent topics in Michele Olivieri's work include CRISPR and Genetic Engineering (3 papers), RNA regulation and disease (2 papers) and HIV Research and Treatment (2 papers). Michele Olivieri is often cited by papers focused on CRISPR and Genetic Engineering (3 papers), RNA regulation and disease (2 papers) and HIV Research and Treatment (2 papers). Michele Olivieri collaborates with scholars based in Italy, Canada and Brazil. Michele Olivieri's co-authors include Antonio Casini, Anna Cereseto, Gianluca Petris, Claudia Montagna, Francesca Lorenzin, Francesca Demichelis, Alberto Inga, Giordano Reginato, Giulia Maule and Davide Prandi and has published in prestigious journals such as Genes & Development, Blood and Nature Biotechnology.

In The Last Decade

Michele Olivieri

11 papers receiving 759 citations

Hit Papers

A highly specific SpCas9 variant is identified by in vivo... 2018 2026 2020 2023 2018 100 200 300

Peers

Michele Olivieri
Michele Olivieri
Citations per year, relative to Michele Olivieri Michele Olivieri (= 1×) peers Yasuhiro Kon

Countries citing papers authored by Michele Olivieri

Since Specialization
Citations

This map shows the geographic impact of Michele Olivieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Olivieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Olivieri more than expected).

Fields of papers citing papers by Michele Olivieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Olivieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Olivieri. The network helps show where Michele Olivieri may publish in the future.

Co-authorship network of co-authors of Michele Olivieri

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Olivieri. A scholar is included among the top collaborators of Michele Olivieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Olivieri. Michele Olivieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Olivieri, Michele & Daniel Durocher. (2021). Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library. STAR Protocols. 2(1). 100321–100321. 14 indexed citations
2.
Hustedt, Nicole, Yuichiro Saito, Michal Zimmermann, et al.. (2019). Control of homologous recombination by the HROB–MCM8–MCM9 pathway. Genes & Development. 33(19-20). 1397–1415. 48 indexed citations
3.
Casini, Antonio, Michele Olivieri, Gianluca Petris, et al.. (2018). A highly specific SpCas9 variant is identified by in vivo screening in yeast. Nature Biotechnology. 36(3). 265–271. 367 indexed citations breakdown →
4.
Avitabile, Concetta, Luca Domenico D’Andrea, Michele Saviano, et al.. (2016). Binding studies of antimicrobial peptides to Escherichia coli cells. Biochemical and Biophysical Research Communications. 478(1). 149–153. 8 indexed citations
5.
Terreri, Sara, Michele Olivieri, Luciana Marinelli, et al.. (2016). Chemical modifications in the seed region of miRNAs 221/222 increase the silencing performances in gastrointestinal stromal tumor cells. European Journal of Medicinal Chemistry. 111. 15–25. 14 indexed citations
6.
Casini, Antonio, Michele Olivieri, Lara Vecchi, Óscar R. Burrone, & Anna Cereseto. (2014). Reduction of HIV-1 Infectivity through Endoplasmic Reticulum-Associated Degradation-Mediated Env Depletion. Journal of Virology. 89(5). 2966–2971. 11 indexed citations
7.
Casini, Antonio, Michele Olivieri, Óscar R. Burrone, & Anna Cereseto. (2013). Reduction of HIV-1 infectivity by exploiting the cellular ERAD machinery. Retrovirology. 10(S1). 1 indexed citations
8.
Sciarra, Alessandro, Roberto Stasi, Elisa Stipa, et al.. (1995). [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma].. PubMed. 86(2). 57–62. 11 indexed citations
9.
Stasi, Roberto, Elisa Stipa, M Masi, et al.. (1994). Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood. 84(12). 4203–4208. 113 indexed citations
10.
Romano, Rossella, Emmanuele A. Jannini, Mario Pepe, et al.. (1991). The effects of iodoprophylaxis on thyroid size during pregnancy. American Journal of Obstetrics and Gynecology. 164(2). 482–485. 100 indexed citations
11.
Jannini, Emmanuele A., Michele Olivieri, Sandro La Vignera, et al.. (1990). Ontogenesis of the Nuclear 3,5,3’-Triiodothyronine Receptor in the Rat Testis. Endocrinology. 126(5). 2521–2526. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026